epa08603487 Workers of the mAbxience laboratory, chosen by AstraZeneca for the production in Latin America of the vaccine against COVID-19, carry out tasks in the plant that the company owns in Garin, in the province of Buenos Aires, Argentina, 14 August 2020. The Argentine laboratory mAbxience is confident that the results of the clinical trial of the vaccine developed by AstraZeneca in collaboration with the British University of Oxford will be positive and that production will begin later this year or early 2021. EPA/Juan Ignacio Roncoroni
Questo sito utilizza i cookie per migliorare servizi e esperienza dei lettori. Se decidi di continuare la navigazione consideriamo che accetti il loro uso.OkLeggi di più